Alopecia Areata

July 1, 2020 / Ameriderm Research

This trial is for patients aged 12 to 70 with alopecia areata. This trial is a double-blind, randomized, placebo treatments controlled study of an oral medication given for 24 weeks with a 28-week open label then 4 week follow-up visit.

The trial is expected to enroll quickly.
CALL TODAY (386) 523-0768 to see if you qualify.

Posted in

Ameriderm Research